Corning Opens Life Sciences Technology Center in Shanghai

We use cookies to ensure the best experience on our website.
View Cookie Policy
_self
Accept Cookie Policy
Change My Settings
ESSENTIAL COOKIES
Required for the site to function.
PREFERENCE AND ANALYTICS COOKIES
Augment your site experience.
SOCIAL AND MARKETING COOKIES
Lets Corning work with partners to enable social features and marketing messages.
ALWAYS ON
ON
OFF

Esta página possui melhor visualização com última versão do Google Chrome e do Mozilla Firefox.

Close[x]
Image Alt Text

Corning Opens Life Sciences Technology Center in Shanghai

Corning Opens Life Sciences Technology Center in S

News Releases
CLS
Corning Opens Life Sciences Technology Center in Shanghai
Corning Opens Life Sciences Technology Center in Shanghai
CORNING, N.Y. | Corning Incorporated | November 12, 2013
Center to provide innovative solutions for customers throughout Asia

Corning Incorporated (NYSE:GLW) held a ceremony today to celebrate the opening of the Corning Life Sciences Asia Technology Center, located in Shanghai’s Jinqiao Technology Development Zone.

Scientists at the center will work with customers from across Asia to help them develop life-changing innovations for the life science industry. Areas of focus will range from new product development to customer process optimization, supporting the region’s significant growth in biological therapies such as vaccines.

“Corning established its reputation as an innovation leader more than 160 years ago. We continue to apply that same dedication today, providing new and better solutions for our life science customers around the world,” said Lydia Kenton Walsh, vice president, commercial operations for Corning Life Sciences, who was keynote speaker and co-host of the event.

“Our goal is to leverage our expertise in both technology and the life science industry to help enable breakthrough discoveries by our customers. Establishing the Corning Life Sciences Asia Technology Center represents a significant milestone in achieving that goal here in Asia,” Kenton Walsh added.

Eric Musser, president, Corning International, co-hosted the event attended by invited guests including customers, distributors and Chinese government officials.

“This technology center will offer Asia researchers the chance to learn about and adopt our leading edge solutions through a variety of hands-on training courses in bioprocessing and drug discovery,” said Douglas L. Lohse, general manager, Corning Life Sciences Greater China, “By forging deeper technical relationships with customers, we aim to shorten their development cycles and improve their productivity.”

The new Corning Life Science Asia Technology Center is co-located with the Corning Science & Technology China Lab at Jinqiao in Shanghai. Corning Life Sciences’ commercial operations for the China region are based in Shanghai, enabling close collaboration with customers in the region.

Forward-Looking and Cautionary Statements
This press release contains “forward-looking statements” (within the meaning of the Private Securities Litigation Reform Act of 1995), which are based on current expectations and assumptions about Corning’s financial results and business operations, that involve substantial risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include: the effect of global political, economic and business conditions; conditions in the financial and credit markets; currency fluctuations; tax rates; product demand and industry capacity; competition; reliance on a concentrated customer base; manufacturing efficiencies; cost reductions; availability of critical components and materials; new product commercialization; pricing fluctuations and changes in the mix of sales between premium and non-premium products; new plant start-up or restructuring costs; possible disruption in commercial activities due to terrorist activity, armed conflict, political or financial instability, natural disasters, adverse weather conditions, or major health concerns; adequacy of insurance; equity company activities; acquisition and divestiture activities; the level of excess or obsolete inventory; the rate of technology change; the ability to enforce patents; product and components performance issues; retention of key personnel; stock price fluctuations; and adverse litigation or regulatory developments. These and other risk factors are detailed in Corning’s filings with the Securities and Exchange Commission. Forward-looking statements speak only as of the day that they are made, and Corning undertakes no obligation to update them in light of new information or future events.

About Corning Incorporated
Corning Incorporated (
  www.corning.com ) is the world leader in specialty glass and ceramics. Drawing on more than 160 years of materials science and process engineering knowledge, Corning creates and makes keystone components that enable high-technology systems for consumer electronics, mobile emissions control, telecommunications and life sciences. Our products include glass substrates for LCD televisions, computer monitors and laptops; ceramic substrates and filters for mobile emission control systems; optical fiber, cable, hardware & equipment for telecommunications networks; optical biosensors for drug discovery; and other advanced optics and specialty glass solutions for a number of industries including semiconductor, aerospace, defense, astronomy, and metrology.